First report ever of a clinical intervention that lowers alkaline phosphatase and improves cardiovascular outcome in patients with CVD. Is this the humble start of a new therapeutic paradigm: targeting ALP for cardiovascular risk reduction?

ASN in beautiful Washington D.C. Proud team presenting exciting new data on a strong association of serum ALP with cognitive impairment (R^2=0.96) in the baseline assessment of BETonMACE

Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment - Kidney International. The underlying cause may determine the association of low bone turnover with outcome, which is not always unfafourable. kidney-international.org/article/S0085-…

Advanced CKD no longer an obstacle for osteoporosis treatment? See new recommendations by IOF & ERA-EDTA: Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism | SpringerLink link.springer.com/article/10.100…

🏆Congratulations Maria Jesús (Susa) Lloret !!!! #bestabstract award in the 6º EUROD Winter Meeting #CKDMBD ERA - European Renal Association S.E.N. Nefrología Societat Catalana de Nefrologia JovSEN

Amazing talk by Lucile Figueres on calcium and magnésium in CKD during the EUROD meeting in Leuven! #EUROD OSCAR Filière ORKiD

What's hot in CKD? Nature Rev Nephrol: Targeting ALP to improve survival.

Joint effort to improve outcome for CKD patients. x.com/kamkalantar/st…